Evidence map›Paper›PMID 42215457›Full record

ArticleNature communications2026

Anaerobic metabolic evolution for homotypic L-valine fermentation.

Siqi Yang, Fenghui Qian, Tao Wu, Bingbing Sun, Huiqi He, Meng Qiao, Feng Dong, Peng Gao, Zhao Chen, Ying Zhang and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Siqi YangKey Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, China.ORCID http://orcid.org/0000-0002-2785-6509
Fenghui QianKey Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, China.
Tao WuMeihua Holdings Group Co., Ltd., Langfang, China.
Bingbing SunKey Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, China.
Huiqi HeKey Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, China.
Meng QiaoKey Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, China.
Feng DongKey Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, China.
Peng GaoMeihua Holdings Group Co., Ltd., Langfang, China.
Zhao ChenMeihua Holdings Group Co., Ltd., Langfang, China.
Ying ZhangBBSRC/EPSRC Synthetic Biology Research Centre (SBRC), Biodiscovery Institute, School of Life Sciences, The University of Nottingham, Nottingham, United Kingdom.ORCID http://orcid.org/0000-0003-3074-9998
Junjie YangKey Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, China.
Yu JiangSchool of Pharmaceutical Sciences, Fudan University, Shanghai, China. jiang_yu@fudan.edu.cn.ORCID http://orcid.org/0000-0002-2943-9960
Sheng YangKey Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, China. syang@sibs.ac.cn.ORCID http://orcid.org/0000-0003-3742-9989

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22595460National Natural Science Foundation of China (National Science Foundation of China) 32371484
6 · The paper itself

Abstract

L-valine is an essential amino acid for animal nutrition. Ideally, it can be produced from D-glucose through homotypic L-valine fermentation in a growth-coupled manner. To date, no known microorganism, native or engineered, can grow on D-glucose and ammonia anaerobically with L-valine as the sole product. Here, we direct the metabolic flux through a reinforced L-valine synthetic pathway by blocking mixed-acid fermentation and L-alanine synthesis reactions to create an NADH driving force in Escherichia coli. We further evolve the engineered strain to debottleneck growth constraints by anaerobic growth rescue. The resulting evolved hyper-valine producer converts D-glucose in a 320 m

Indexed as

Escherichia coliFermentationValineAnaerobiosisBioreactorsGlucoseMetabolic EngineeringNADGlucoseNADValine

Identifiers

PMID42215457
PMCPMC13392391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.